Pozen Inc. announced the acquisition of Tribute Pharmaceuticals Canada Inc., a Canadian specialty pharmaceutical company, in a transaction valued at...
The FDA has approved the New Drug Application (NDA) for Tuzistra XR (codeine polistirex and chlorpheniramine polistirex) extended-release oral suspension,...